99310-43-7

Usage

Uses

Used in Pharmaceutical Industry:
2-Piperidinepropanoic acid, hydrochloride is used as a pharmaceutical intermediate for the synthesis of drugs that act on the central nervous system, due to its structural properties that facilitate the creation of compounds with specific therapeutic effects.
Used in Central Nervous System Medications:
In the field of neurology and psychiatry, 2-Piperidinepropanoic acid, hydrochloride is utilized as a starting material in the development of medications for conditions such as anxiety, depression, and schizophrenia, leveraging its ability to interact with neurotransmitter systems in the brain.
Used in Anti-Inflammatory and Analgesic Medications:
2-Piperidinepropanoic acid, hydrochloride is also being investigated for its potential use as an anti-inflammatory and analgesic agent, suggesting that it may contribute to the management of pain and inflammation through its chemical interactions within the body.

Upstream product

• 669713-96-6 3-{1-[(tert-butoxy)carbonyl]piperidin-2-yl}propanoic acid 
• 15197-75-8 3-(pyridin-2-yl)propanoic acid 
• 7440-44-0 pyrographite 
• 10294-56-1 phosphorous acid 
• 7340-22-9 3-pyridin-2-yl-acrylic acid 
• 50610-14-5 methyl 3-(pyridin-2-yl)acrylate 

Downstream Products

• 7599-21-5 3-[2]piperidyl-propionic acid ethyl ester; hydrochloride 
• 1021204-95-4 methyl 3-[1-(4-chloro-2,5-dimethyl-phenylsulfonyl)-piperidin-2-yl]-propionate 
• 741269-65-8 C₁₆H₂₀BrNO₃ 
• 1021204-82-9 3-[1-(4-chloro-2,5-dimethyl-phenylsulfonyl)-piperidin-2-yl]-propionic acid 
• 1190971-03-9 3-(1-(4-chloro-2,5-dimethylphenylsulfonyl)piperidin-2-yl)propionic acid ethyl ester 
• 1186240-28-7 N-((1-(3-(1-(4-chloro-2,5-dimethylphenylsulfonyl)piperidin-2-yl)propanoyl)-4-(4-methylpiperazin-1-yl)piperidin-4-yl)methyl)acetamide 

Relevant academic research and scientific papers

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

TRICYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE

A compound of the formula: wherein R1 is a 5- or 6-membered ring; ???Z1 is a 5- or 6-membered aromatic ring; ???Z2 is a group of -Z2a-W2-Z2b-, wherein Z2a and Z2b are each O, S(O)q (wherein q is 0, 1 or 2), an imino group, or a bond; and W2 is an alkylene chain; ???W is a group represented by wherein R3 and R3' are each a hydrogen atom, a lower alkyl group, or a lower alkoxy group; X is CH or N; n and n' are each an integer of 0 or 1 to 4; m and m' are each 1 or 2; Y is O, S(O)p (wherein p is 0, 1 or 2), CH2 or NR4 (wherein R4 is a hydrogen atom, a lower alkyl group, or a lower acyl group); and ???R2 is (1) an amino group, in which the nitrogen atom may be converted to a quaternary ammonium or an oxide, or (2) a nitrogen-containing heterocyclic group which may contain a sulfur atom or an oxygen atom as the ring-constituting atom, in which the nitrogen atommay be converted to a quaternary ammonium or an oxide; or a salt thereof. The compound exhibits excellent CCR antagonist activity against CCR5, and is useful as a prophylactic and/or therapeutic agent for HIV infection in human peripheral blood mononuclear cells, especially for AIDS.

Diphosphonic acid derivatives, pharmaceutical compositions and methods

The present invention provides diphosphonic acid derivatives of the general formula: STR1 according to claim 1. These compounds are useful for the treatment or prophylaxis of calcium metabolism disturbance or disease.